# A Weak Supervision Approach for Monitoring Recreational Drug Use Effects in Social Media

**Korean Title:** ì•½ë¬¼ ì‚¬ìš© íš¨ê³¼ ëª¨ë‹ˆí„°ë§ì„ ìœ„í•œ ì•½í•œ ê°ë… ì ‘ê·¼ë²•: ì†Œì…œ ë¯¸ë””ì–´ì—ì„œì˜ ì‚¬ë¡€ ì—°êµ¬

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily/2025-09-22|2025-09-22]] [[categories/cs.AI|cs.AI]]

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸš€ Evolved Concepts**: Real-time Pharmacovigilance

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-18/A Comparative Analysis of Transformer Models in Social Bot Detection_20250918|A Comparative Analysis of Transformer Models in Social Bot Detection]] (78.2% similar)
- [[2025-09-18/An Attention-Based Denoising Framework for Personality Detection in Social Media Texts_20250918|An Attention-Based Denoising Framework for Personality Detection in Social Media Texts]] (77.5% similar)
- [[2025-09-19/SMARTER_ A Data-efficient Framework to Improve Toxicity Detection with Explanation via Self-augmenting Large Language Models_20250919|SMARTER A Data-efficient Framework to Improve Toxicity Detection with Explanation via Self-augmenting Large Language Models]] (77.2% similar)
- [[2025-09-22/Network-Based Detection of Autism Spectrum Disorder Using Sustainable and Non-invasive Salivary Biomarkers_20250922|Network-Based Detection of Autism Spectrum Disorder Using Sustainable and Non-invasive Salivary Biomarkers]] (76.6% similar)
- [[2025-09-19/Translate, then Detect_ Leveraging Machine Translation for Cross-Lingual Toxicity Classification_20250919|Translate, then Detect Leveraging Machine Translation for Cross-Lingual Toxicity Classification]] (76.3% similar)

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.15266v1 Announce Type: new 
Abstract: Understanding the real-world effects of recreational drug use remains a critical challenge in public health and biomedical research, especially as traditional surveillance systems often underrepresent user experiences. In this study, we leverage social media (specifically Twitter) as a rich and unfiltered source of user-reported effects associated with three emerging psychoactive substances: ecstasy, GHB, and 2C-B. By combining a curated list of slang terms with biomedical concept extraction via MetaMap, we identified and weakly annotated over 92,000 tweets mentioning these substances. Each tweet was labeled with a polarity reflecting whether it reported a positive or negative effect, following an expert-guided heuristic process. We then performed descriptive and comparative analyses of the reported phenotypic outcomes across substances and trained multiple machine learning classifiers to predict polarity from tweet content, accounting for strong class imbalance using techniques such as cost-sensitive learning and synthetic oversampling. The top performance on the test set was obtained from eXtreme Gradient Boosting with cost-sensitive learning (F1 = 0.885, AUPRC = 0.934). Our findings reveal that Twitter enables the detection of substance-specific phenotypic effects, and that polarity classification models can support real-time pharmacovigilance and drug effect characterization with high accuracy.

## ğŸ” Abstract (í•œê¸€ ë²ˆì—­)

arXiv:2509.15266v1 ë°œí‘œ ìœ í˜•: ì‹ ê·œ  
ì´ˆë¡: ë ˆí¬ë¦¬ì—ì´ì…˜ ì•½ë¬¼ ì‚¬ìš©ì˜ ì‹¤ì œ íš¨ê³¼ë¥¼ ì´í•´í•˜ëŠ” ê²ƒì€ ê³µì¤‘ ë³´ê±´ ë° ìƒì˜í•™ ì—°êµ¬ì—ì„œ ì—¬ì „íˆ ì¤‘ìš”í•œ ê³¼ì œì…ë‹ˆë‹¤. íŠ¹íˆ ì „í†µì ì¸ ê°ì‹œ ì‹œìŠ¤í…œì€ ì‚¬ìš©ì ê²½í—˜ì„ ì¢…ì¢… ê³¼ì†Œ ëŒ€í‘œí•˜ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤. ë³¸ ì—°êµ¬ì—ì„œëŠ” ì†Œì…œ ë¯¸ë””ì–´(íŠ¹íˆ íŠ¸ìœ„í„°)ë¥¼ í™œìš©í•˜ì—¬ ì—‘ìŠ¤í„°ì‹œ, GHB, 2C-Bë¼ëŠ” ì„¸ ê°€ì§€ ì‹ í¥ í–¥ì •ì‹ ì„± ë¬¼ì§ˆê³¼ ê´€ë ¨ëœ ì‚¬ìš©ì ë³´ê³  íš¨ê³¼ì˜ í’ë¶€í•˜ê³  í•„í„°ë§ë˜ì§€ ì•Šì€ ì¶œì²˜ë¡œ í™œìš©í–ˆìŠµë‹ˆë‹¤. ì€ì–´ ìš©ì–´ì˜ íë ˆì´ì…˜ ëª©ë¡ê³¼ MetaMapì„ í†µí•œ ìƒì˜í•™ ê°œë… ì¶”ì¶œì„ ê²°í•©í•˜ì—¬ ì´ëŸ¬í•œ ë¬¼ì§ˆì„ ì–¸ê¸‰í•˜ëŠ” 92,000ê°œ ì´ìƒì˜ íŠ¸ìœ—ì„ ì‹ë³„í•˜ê³  ì•½í•˜ê²Œ ì£¼ì„ì„ ë‹¬ì•˜ìŠµë‹ˆë‹¤. ê° íŠ¸ìœ—ì€ ì „ë¬¸ê°€ê°€ ì•ˆë‚´í•˜ëŠ” íœ´ë¦¬ìŠ¤í‹± í”„ë¡œì„¸ìŠ¤ë¥¼ ë”°ë¼ ê¸ì •ì  ë˜ëŠ” ë¶€ì •ì  íš¨ê³¼ë¥¼ ë³´ê³ í–ˆëŠ”ì§€ ì—¬ë¶€ë¥¼ ë°˜ì˜í•˜ëŠ” ê·¹ì„±ìœ¼ë¡œ ë ˆì´ë¸”ì´ ì§€ì •ë˜ì—ˆìŠµë‹ˆë‹¤. ê·¸ëŸ° ë‹¤ìŒ ë¬¼ì§ˆ ê°„ ë³´ê³ ëœ í‘œí˜„í˜• ê²°ê³¼ì— ëŒ€í•œ ê¸°ìˆ ì  ë° ë¹„êµ ë¶„ì„ì„ ìˆ˜í–‰í•˜ê³ , ë¹„ìš© ë¯¼ê° í•™ìŠµ ë° í•©ì„± ì˜¤ë²„ìƒ˜í”Œë§ê³¼ ê°™ì€ ê¸°ë²•ì„ ì‚¬ìš©í•˜ì—¬ ê°•í•œ í´ë˜ìŠ¤ ë¶ˆê· í˜•ì„ ê³ ë ¤í•˜ì—¬ íŠ¸ìœ— ì½˜í…ì¸ ì—ì„œ ê·¹ì„±ì„ ì˜ˆì¸¡í•˜ê¸° ìœ„í•´ ì—¬ëŸ¬ ê¸°ê³„ í•™ìŠµ ë¶„ë¥˜ê¸°ë¥¼ í›ˆë ¨í–ˆìŠµë‹ˆë‹¤. í…ŒìŠ¤íŠ¸ ì„¸íŠ¸ì—ì„œ ìµœê³ ì˜ ì„±ëŠ¥ì€ ë¹„ìš© ë¯¼ê° í•™ìŠµì„ ì‚¬ìš©í•œ eXtreme Gradient Boostingì—ì„œ ì–»ì—ˆìŠµë‹ˆë‹¤(F1 = 0.885, AUPRC = 0.934). ìš°ë¦¬ì˜ ì—°êµ¬ ê²°ê³¼ëŠ” íŠ¸ìœ„í„°ê°€ ë¬¼ì§ˆë³„ í‘œí˜„í˜• íš¨ê³¼ë¥¼ ê°ì§€í•  ìˆ˜ ìˆìŒì„ ë³´ì—¬ì£¼ë©°, ê·¹ì„± ë¶„ë¥˜ ëª¨ë¸ì´ ë†’ì€ ì •í™•ë„ë¡œ ì‹¤ì‹œê°„ ì•½ë¬¼ ê°ì‹œ ë° ì•½ë¬¼ íš¨ê³¼ íŠ¹ì„±í™”ë¥¼ ì§€ì›í•  ìˆ˜ ìˆìŒì„ ë³´ì—¬ì¤ë‹ˆë‹¤.

## ğŸ“ ìš”ì•½

ì´ ì—°êµ¬ëŠ” ì†Œì…œ ë¯¸ë””ì–´, íŠ¹íˆ íŠ¸ìœ„í„°ë¥¼ í™œìš©í•˜ì—¬ ì—‘ìŠ¤í„°ì‹œ, GHB, 2C-Bì™€ ê°™ì€ ì‹ ì¢… í–¥ì •ì‹ ì„± ë¬¼ì§ˆì˜ ì‚¬ìš©ì ë³´ê³  íš¨ê³¼ë¥¼ ë¶„ì„í–ˆìŠµë‹ˆë‹¤. ìŠ¬ë­ ìš©ì–´ì™€ MetaMapì„ ì‚¬ìš©í•˜ì—¬ 92,000ê°œ ì´ìƒì˜ ê´€ë ¨ íŠ¸ìœ—ì„ ì‹ë³„í•˜ê³  ê¸ì •ì  ë˜ëŠ” ë¶€ì •ì  íš¨ê³¼ë¡œ ë¶„ë¥˜í–ˆìŠµë‹ˆë‹¤. ë‹¤ì–‘í•œ ê¸°ê³„ í•™ìŠµ ë¶„ë¥˜ê¸°ë¥¼ í†µí•´ íŠ¸ìœ— ë‚´ìš©ì—ì„œ íš¨ê³¼ì˜ ê·¹ì„±ì„ ì˜ˆì¸¡í–ˆìœ¼ë©°, eXtreme Gradient Boostingì´ ê°€ì¥ ë†’ì€ ì„±ëŠ¥ì„ ë³´ì˜€ìŠµë‹ˆë‹¤(F1 = 0.885, AUPRC = 0.934). ì´ ì—°êµ¬ëŠ” íŠ¸ìœ„í„°ê°€ ì•½ë¬¼ì˜ êµ¬ì²´ì ì¸ íš¨ê³¼ë¥¼ ê°ì§€í•˜ëŠ” ë° ìœ ìš©í•˜ë©°, ê·¹ì„± ë¶„ë¥˜ ëª¨ë¸ì´ ì‹¤ì‹œê°„ ì•½ë¬¼ ê°ì‹œì™€ íš¨ê³¼ íŠ¹ì„±í™”ì— ë†’ì€ ì •í™•ë„ë¡œ ê¸°ì—¬í•  ìˆ˜ ìˆìŒì„ ë³´ì—¬ì¤ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ë³¸ ì—°êµ¬ëŠ” íŠ¸ìœ„í„° ë°ì´í„°ë¥¼ í™œìš©í•˜ì—¬ ì—‘ìŠ¤í„°ì‹œ, GHB, 2C-Bì™€ ê°™ì€ ì‹ ì¢… í–¥ì •ì‹ ì„± ë¬¼ì§ˆì˜ ì‚¬ìš©ì ë³´ê³  íš¨ê³¼ë¥¼ ë¶„ì„í–ˆìŠµë‹ˆë‹¤.

- 2. MetaMapì„ ì‚¬ìš©í•˜ì—¬ 92,000ê°œ ì´ìƒì˜ íŠ¸ìœ—ì„ ì•½í•œ ì£¼ì„ìœ¼ë¡œ ë¶„ë¥˜í•˜ê³ , ê¸ì •ì  ë˜ëŠ” ë¶€ì •ì  íš¨ê³¼ë¥¼ ë°˜ì˜í•˜ëŠ” ê·¹ì„±ì„ ë¶€ì—¬í–ˆìŠµë‹ˆë‹¤.

- 3. íŠ¸ìœ— ë‚´ìš©ì—ì„œ ê·¹ì„±ì„ ì˜ˆì¸¡í•˜ê¸° ìœ„í•´ ì—¬ëŸ¬ ë¨¸ì‹ ëŸ¬ë‹ ë¶„ë¥˜ê¸°ë¥¼ í›ˆë ¨í–ˆìœ¼ë©°, eXtreme Gradient Boostingì´ ê°€ì¥ ë†’ì€ ì„±ëŠ¥ì„ ë³´ì˜€ìŠµë‹ˆë‹¤.

- 4. íŠ¸ìœ„í„°ëŠ” ë¬¼ì§ˆë³„ íŠ¹ì´ì  í‘œí˜„í˜• íš¨ê³¼ë¥¼ ê°ì§€í•  ìˆ˜ ìˆìœ¼ë©°, ê·¹ì„± ë¶„ë¥˜ ëª¨ë¸ì€ ì‹¤ì‹œê°„ ì•½ë¬¼ ê°ì‹œì™€ íš¨ê³¼ íŠ¹ì„±í™”ì— ë†’ì€ ì •í™•ë„ë¡œ ê¸°ì—¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.

---

*Generated on 2025-09-22 15:09:06*